Boston Pharma appoints Ian Sanderson as CFO
Mr. Sanderson joins Boston Pharmaceuticals from Catabasis Pharmaceuticals, where he was Chief Financial Officer. While at Catabasis, he oversaw operations and led the company’s re-positioning and successful IPO in 2015.
Prior to joining Catabasis, Mr. Sanderson was a senior advisor with JSB Partners, advising life sciences companies on corporate finance, M&A and business development transactions.
Before JSB Partners, he spent 20 years with Cowen and Company, most recently as a Managing Director and Senior Pharmaceuticals Analyst, leading Cowen’s emerging and specialty pharmaceuticals research team.
Prior to his pharmaceuticals research analyst career, Mr. Sanderson was a health care investment banker with Cowen and Houlihan Lokey. He began his healthcare career in the finance group of U.S. Surgical Corporation (now Medtronic).
Mr. Sanderson earned an MBA in finance from the Wharton School and a BA in Political Economy from Williams College. ■
LATEST MOVES FROM Massachusetts
- RXI Pharma names Gerrit Dispersyn chief development officer
- resTORbio appoints Joan Mannick as CMO
- C&W Services appoints Mike Losier as director
- Charles River Associates appoints Robert A. Whitman to board
- Ironwood Pharmaceuticals appoints Christopher Wright as SVP
More inside POST
Iran Air, ATR sign plane purchase deal Companies